Femiject, a once-a-month combined injectable contraceptive: experience from Pakistan.
CONCLUSION: As the continuation rate, level of satisfaction and bleeding profile of CIC users was promising, increased uptake should be encouraged. Our study shows that CIC is a good option for women requesting contraception.
PMID: 32757796 [PubMed - as supplied by publisher]
Source: The European Journal of Contraception and Reproductive Health Care - Category: Reproduction Medicine Authors: Izhar R, Husain S, Tahir MA, Husain S Tags: Eur J Contracept Reprod Health Care Source Type: research
More News: Bleeding | Health Management | Medroxyprogesterone | Pakistan Health | Reproduction Medicine | Study | Women